IntelliPharmaCeutics International Inc logo

IntelliPharmaCeutics International Inc

OTCPK:IPCIF (Canada)  
$ 0.06 0 (0%) 10:08 PM EST
At Loss
Volume:
-
Avg Vol (2M):
8.00K
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
8.00K

Business Description

Description
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.18
Equity-to-Asset -8.22
Debt-to-Equity -0.17
Debt-to-EBITDA -0.82
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -111.84
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 38.22
9-Day RSI 45.29
14-Day RSI 47.47
6-1 Month Momentum % 20.48
12-1 Month Momentum % 66.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.06
Quick Ratio 0.06
Cash Ratio 0.03
Days Sales Outstanding 73.44
Days Payable 78681.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.4
Shareholder Yield % -18.68

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 98.03
Operating Margin % -279.12
Net Margin % -350.12
FCF Margin % 13.37
ROA % -205.83
ROIC % -77.92
ROC (Joel Greenblatt) % -349.02

Financials

IPCIF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IPCIF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

IntelliPharmaCeutics International Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.905
EPS (TTM) ($) -0.092
Beta 1.02
Volatility % 182.78
14-Day RSI 47.47
14-Day ATR ($) 0.020985
20-Day SMA ($) 0.06862
12-1 Month Momentum % 66.94
52-Week Range ($) 0.0213 - 0.13758
Shares Outstanding (Mil) 33.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IntelliPharmaCeutics International Inc Filings

Filing Date Document Date Form
No Filing Data

IntelliPharmaCeutics International Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

IntelliPharmaCeutics International Inc Frequently Asked Questions

What is IntelliPharmaCeutics International Inc(IPCIF)'s stock price today?
The current price of IPCIF is $0.06. The 52 week high of IPCIF is $0.14 and 52 week low is $0.02.
When is next earnings date of IntelliPharmaCeutics International Inc(IPCIF)?
The next earnings date of IntelliPharmaCeutics International Inc(IPCIF) is .
Does IntelliPharmaCeutics International Inc(IPCIF) pay dividends? If so, how much?
IntelliPharmaCeutics International Inc(IPCIF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1